3191 results for «550»
3191 results
Learnings from an optimised TAVI patient's journey
18 May 2022 – From EUROPCR 2022
What are the best practices related to referring and in-hospital patient pathways? How and which TAVI procedural aspects can be optimised for the greater good of the patient and the healthcare system?
Watch this EuroPCR 2022 session to discover how an optimised TAVI care pathway offers...
Left main bifurcations: latest clinical data applied to practical cases
18 May 2022 – From EUROPCR 2022
Why should the stenting strategy be adapted to side branch lesion length? How to use intracoronary imaging to improve outcomes? This session will address those questions and show you through a series of cases, examples of left main PCI from the European Bifurcation Club main trial...
TricValve - Addressing the unmet need for patients with right heart failure and functional tricuspid regurgitation - Real-life clinical outcomes
18 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to learn all about the latest treatment option for patients with severe TR, to discover the supporting clinical evidence of TricValve, and to understand how the TricValve Transcatheter Bicaval Valves System can improve patient's quality of life.
Your most challenging TAVI cases - Achieving precision and control with Evolut platform
18 May 2022 – From EuroPCR 2022
How to deal with challenging anatomies? Find answers in this EuroPCR 2022 session with case studies to explore and learn how to achieve optimal patient outcomes with Evolut platform, uncover practical tips and techniques to achieve implant precision and control, and become familiar with technical considerations and procedural execution...
A new focus on mitral and tricuspid valve disease
18 May 2022 – From EuroPCR 2022
Find out more about the need for transcatheter replacement in the atrioventricular valves and the Intrepid programme, the potential of transvenous transseptal versus transapical access to the mitral valve, and the future of transvenous tricuspid valve replacement in this EuroPCR 2022 session.
Incorporating coronary orbital atherectomy to my practice
18 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to examine the improvement of technology in the treatment of highly calcified coronary lesions: get a practical perspective on how to integrate and perform orbital atherectomy in your clinical practice, become aware of its differential aspects compared to other plaque preparation...
Coronary microvascular dysfunction in case examples: invisible, measurable, treatable
18 May 2022 – From EuroPCR 2022
In this very practical session from EuroPCR 2022 focusing on microcirculation, learn how to perform a step-by-step assessment of the coronary microcirculation in the cathlab, discuss the whole management of patients with coronary microvascular dysfunction (CMD), and understand how to use coronary flow reserve (CFR) and index...
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary stenting: SORT OUT VIII, ROLEX, FANTOM II, and more!
18 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary stenting! FANTOM II trial, five-year follow-up in the SORT OUT VIII trial, impact of side branch disease pattern on outcome following left main PCI, intravascular imaging vs. angiography-guided PCI in high bleeding risk patients, safety and...
Treatment of small vessel disease - To stent or not to stent?
07 Oct 2022 – From AICT-AsiaPCR 2022
Consult this session if you want to learn the tips and tricks to perform a small vessel disease intervention and to discuss the pros and cons of treating small vessel disease with DCB and/or DES.
M-TEER for primary mitral regurgitation
08 Feb 2025 – From PCR Tokyo Valves 2025
In this PCR Tokyo Valves 2025 session on M-TEER for primary mitral regurgitation, gain valuable insights starting with an overview of current TEER devices. Benefit from four case studies that highlight the features of these devices, explore strategies to prevent mitral regurgitation recurrence post-TEER, and delve...
M-TEER around the world
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest insights and advancements in the field of Mitral Transcatheter Edge-to-Edge Repair (M-TEER) from around the world. Discover a new anatomical risk score for predicting procedural outcomes, two-year outcomes from the MiCLASP study, the impact of regurgitant volume to left atrial volume ratio on...
TAVI complications: hemolytic anemia, prosthetic valve endocarditis & stroke
08 Feb 2025 – From PCR Tokyo Valves 2025
Gain valuable insights into the management of complications associated with Transcatheter Aortic Valve Implantation (TAVI). Discover the latest evidence on hemolytic anemia, the predictive value of the hemoglobin to creatinine ratio, outcomes of transcarotid TAVI, a case study on prosthetic valve endocarditis, the role of diastolic...
M-TEER difficult situation: small mitral valves, P2 prolapse & leaflet degeneration
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore a series of challenging cases in Mitral Transcatheter Edge-to-Edge Repair (M-TEER), highlighting the versatility and adaptability of this technique. Discover how M-TEER can be successfully applied in patients with extremely small mitral valves, P2 prolapse supported by chordae from the posterior papillary muscle, wide prolapse...
TAVI complications cases - Part 1
08 Feb 2025 – From PCR Tokyo Valves 2025
Dive into the world of TAVI complications in this comprehensive session. Explore a range of challenging cases, including bailout implantation of an embolized self-expandable valve, ascending aortic dissection, coronary embolization, cardiac tamponade, and annular rupture. Gain insights into the management strategies and specialized techniques employed to...
Late-Breaking Trial session
08 Feb 2025 – From PCR Tokyo Valves 2025
Discover the latest insights from pivotal studies in this PCR Tokyo Valves 2025 LBT session. Explore early feasibility updates from the AltaValve trial, in-hospital outcomes comparing surgical vs. percutaneous intervention in aortic stenosis with coronary artery disease from the JROAD-DPC data, and procedural results from the...
TAV-in-SAV - Part 1
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the complex world of TAV-in-SAV (Transcatheter Aortic Valve-in-Surgical Aortic Valve) in this comprehensive session. Explore various case studies, including valve-in-valve TAVI in a patient with structural valve deterioration, a successful case of balloon-assisted BASILICA for TAV-in-TAV, and TAVI after valve sparing aortic replacement. Gain...
TAVI access issues
08 Feb 2025 – From PCR Tokyo Valves 2025
Dive into the challenges and innovative solutions surrounding TAVI access issues in this comprehensive session. Discover a one-step operation of transcarotid TAVI and PDA occlusion, a bailout case of transfemoral TAVI through a severely bent and calcified aorta, the role of transcaval access in hostile peripheral...
How to optimise the patient outcomes - Key considerations for the small body population
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest strategies for optimizing outcomes in Asian and international patients with small body size. Through case presentations, surgical experiences, and the latest data on device performance, gain valuable insights into treating aortic stenosis more effectively. Discover how these advancements can enhance patient care and...
Maximising the potential of MitraClip in TEER therapy
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest advancements in TEER therapy with this PCR Tokyo Valves 2025 session dedicated to MitraClip. Through expert-led case discussions, gain a deeper understanding of complex scenarios, including restricted posterior leaflet in functional mitral regurgitation, commissure lesion (A3P3), and MitraClip combined with Amulet.
This session also...
Challenging situations in M-TEER: Takotsubo syndrome
08 Feb 2025 – From PCR Tokyo Valves 2025
Dive into this session to explore challenging situations in Mitral Transcatheter Edge-to-Edge Repair (M-TEER). Discover case studies showcasing a range of complex scenarios, including Takotsubo syndrome following M-TEER, successful TEER with improved visualization using a bronchial blocker, managing cardiac arrest during MitraClip procedures, and more. Gain...
